This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2010 Jul;11(4):221-3.

doi: 10.1007/s11934-010-0117-5.

Proven efficacy of combined androgen depletion therapy

Hideyuki Akaza¹

Affiliations

PMID: 20461479
DOI: 10.1007/s11934-010-0117-5

Comment

Proven efficacy of combined androgen depletion therapy

Hideyuki Akaza. Curr Urol Rep. 2010 Jul.

. 2010 Jul;11(4):221-3.

doi: 10.1007/s11934-010-0117-5.

Author

Hideyuki Akaza¹

Affiliation

¹ Research Center for Advanced Science and Technology, The University of Tokyo, Komaba, Meguroku, Tokyo, 053-8904, Japan. akazah@med.rcast.u-tokyo.ac.jp

PMID: 20461479
DOI: 10.1007/s11934-010-0117-5

No abstract available

PubMed Disclaimer

Comment on

Combined androgen blockade with bicalutamide for advanced prostate cancer: long-term follow-up of a phase 3, double-blind, randomized study for survival.
Akaza H, Hinotsu S, Usami M, Arai Y, Kanetake H, Naito S, Hirao Y; Study Group for the Combined Androgen Blockade Therapy of Prostate Cancer. Akaza H, et al. Cancer. 2009 Aug 1;115(15):3437-45. doi: 10.1002/cncr.24395. Cancer. 2009. PMID: 19536889 Clinical Trial.

References

1. Jpn J Clin Oncol. 2004 Jan;34(1):20-8 - PubMed
1. BJU Int. 2004 Jun;93(9):1177-82 - PubMed
1. Prostate Cancer Prostatic Dis. 2007;10(2):194-201 - PubMed
1. J Clin Oncol. 2007 Apr 20;25(12):1596-605 - PubMed
1. J Clin Oncol. 2009 Sep 10;27(26):4306-13 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Springer